WASHINGTON (Reuters) - AstraZeneca Plc is urging U.S. lawmakers to revive a program for drugmakers who want to voluntarily submit their television commercials for regulatory review, according to a ...

AstraZeneca will end U.S. commercial sales of Andexxa Dec. 22, citing safety concerns raised in postmarketing data and a recent trial, according to a ...

AstraZeneca reported $45.8bn in revenues for 2023, a 6% gain from the previous year on a CER basis. EPS of $7.26 was up 15% year-over-year. The company's oncology division accounted for 37% of total ...

Patients and caregivers may be one step closer to having the ability to give themselves or someone else a flu vaccine without having to go to a pharmacy or clinic. The Food and Drug Administration ...

On Thursday, the FDA accepted and granted Priority Review to AstraZeneca Plc’s (NASDAQ:AZN) supplemental marketing application for Calquence (acalabrutinib) for adult patients with previously ...

FDA grants Priority Review to AstraZeneca’s Imfinzi sBLA for muscle-invasive bladder cancer, with decision expected in Q2 2025. Imfinzi regimen showed a 32% reduced risk of disease progression and a ...

A data and safety monitoring board formed by the National Institute for Allergy and Infectious Diseases made a rare move when it published a statement March 23 saying AstraZeneca's March 22 ...

The U.S. Food and Drug Administration (FDA) granted priority review to AstraZeneca's (NASDAQ:AZN) application seeking expanded approval of Tagrisso to treat certain patients with a type of non-small ...

Even amid concerns that have led an increasing number of countries to stop distributing the COVID-19 vaccine produced by AstraZenecaa, the World Health Organization is urging its continued use. The ...

AstraZeneca AZN announced that its new drug application (NDA) for capivasertib in combination with Faslodex (fulvestrant) has been accepted and granted priority review by the FDA. The NDA is seeking ...

Nov 1 (Reuters) - AstraZeneca Plc (AZN.L), opens new tab said on Sunday Britain's health regulator had started an accelerated review of its potential coronavirus vaccine. "We confirm the MHRA's ...

Police in China have detained five current and former employees of British drugmaker AstraZeneca Plc for questioning about potential illegal activities, according to people familiar with the matter.